EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
- PMID: 30037941
- PMCID: PMC6058342
- DOI: 10.1634/theoncologist.2017-0301erratum
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
Erratum for
-
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.Oncologist. 2018 May;23(5):631-636. doi: 10.1634/theoncologist.2017-0301. Epub 2017 Nov 30. Oncologist. 2018. PMID: 29192015 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
